Skip to main content
. 2016 Feb 2;8:2. doi: 10.1186/s13099-016-0086-4

Table 1.

Date on pneumocystis pneumonia during administrarion of infliximab

No. Reference Year Sex Age at diagnosis (years) Crohn’s disease duration IFX duration Dose of IFX Concomitant drug(s) Medication Clinical course
1 Seddik et al. [6] 2004 Male 29 ND 1 month 5 mg/kg PSL + AZA ST 2 weeks alive
2 Velayos et al. [7] 2004 Male 19 2 years 2 years 3 months 5 mg/kg AZA ST + PSL 2 weeks alive
3 Kaur et al. [8] 2004 Male 59 3 weeks 9 weeks ND PSL ST + PM 1 month died
4 Stratakos et al. [9] 2005 Female 77 9 months 8 months 5 mg/kg mPSL + AZA ST 6 month alive
5 Itaba et al. [10] 2007 Female 57 21 years 5 weeks 5 mg/kg PSL + AZA ST + mPSL 4 month alive
6 金井 et al. [11] 2009 Male 69 44 years 4 weeks 5 mg/kg 5-ASA + PSL ST + mPSL 6 month alive
7 Tshudy et al. [12] 2010 Male 8 6 years 15 months 5 mg/kg None ST 4 weeks alive
8 Present case 2014 Male 51 24 years 10 years 10 mg/kg 6-MP (0.15 g/day) ST 1 year 5 month alive

ST sulfamethoxazole/trimethoprim, PSL prednisolone, mPSL methylprednisolone, PM pentamidine, AZA azathioprine, 5-ASA mesalazine, 6-MP 6mercaptopurine, ND not described